Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Mirum Pharmaceuticals, Inc. (MIRM), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-5.50
P/B ratioShare price divided by book value per share.
-487.32
P/S ratioMarket value divided by annual revenue.
8.42
PEG ratioP/E divided by the earnings growth rate.
0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-7.25
EV / RevenueEnterprise value against annual revenue.
9.11
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-16.92%
Free cash flow yieldFree cash flow as a percentage of market value.
-8.80%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
81.70%
Operating marginRevenue left after operating costs.
-17.42%
Net marginRevenue left after every cost, including tax and interest.
-139.18%
Return on equityProfit as a percentage of shareholders’ equity.
-410.20%
Return on assetsProfit as a percentage of total assets.
-82.32%
Return on capital employedOperating profit against the capital the business uses.
-13.09%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.86
Quick ratioThe same, excluding inventory.
2.74
Cash ratioCash alone against current liabilities.
1.44
Debt to equityTotal borrowings against shareholders’ equity.
-72.97
Debt to assetsTotal borrowings against total assets.
0.38
Interest coverageHow many times operating profit covers the interest bill.
-8.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-0.47
Book value per shareShareholders’ equity divided by shares outstanding.
$3.98
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$5.22B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$5.85B
EmployeesReported headcount.
418
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Mirum Pharmaceuticals, Inc. (MIRM) statistics — frequently asked questions
What is Mirum Pharmaceuticals, Inc.'s P/E ratio?
Mirum Pharmaceuticals, Inc. (MIRM) trades on a price-to-earnings ratio of -5.50. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Mirum Pharmaceuticals, Inc.'s return on equity?
Mirum Pharmaceuticals, Inc. (MIRM) reports a return on equity of -410.20%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Mirum Pharmaceuticals, Inc. carry?
Mirum Pharmaceuticals, Inc. (MIRM) has a debt-to-equity ratio of -72.97, which compares total borrowings with shareholders' equity.
What is Mirum Pharmaceuticals, Inc.'s profit margin?
Mirum Pharmaceuticals, Inc. (MIRM) keeps -139.18% of revenue as net profit after every cost, including tax and interest.